United States Biotechnology & Medical Research

Marker Therapeutics Inc (MRKR)

Track

Ticker: MRKR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 23 Dec 2024
Value US$3,137,160.78 | Price 68.90 | Shares 56,912 (+20.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-26 2024-12-23 B Purchase
2.6
ELMS STEVE
Non-Executive Director
56,912 +20.9%
68.90
US$3,137,161 		56,912 +20.9% 68.90 US$3,137,161
2024-12-23 2024-12-23 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
35,258 +47.7%
241.20
US$4,285,061 		35,258 +47.7% 241.20 US$4,285,061
2023-06-08 2021-03-16 B Purchase
3.6
Eansor Norman David
Non-Executive Director
264 -21.1%
439.70
US$3,817,317 		264 -21.1% 439.70 US$3,817,317
2021-03-18 2021-03-16 B Purchase
2.6
ELMS STEVE
Non-Executive Director
1,142,857 +57.1%
1.75
US$2,000,000 		1,142,857 +57.1% 1.75 US$2,000,000
2021-03-18 2021-03-16 B Purchase
3.2
Vera Juan

Chief Development Officer

Officer
571,428 +28.7%
1.75
US$999,999 		571,428 +28.7% 1.75 US$999,999
2021-03-18 2021-03-16 B Purchase
2.1
Sonsini Peter W.
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
2.9
Makhzoumi Mohamad
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
Wilson John Robert
Non-Executive Director
1,714,285 +28.2%
1.75
US$2,999,999 		1,714,285 +28.2% 1.75 US$2,999,999
2021-03-18 2021-03-16 B Purchase
Hoang Peter L.

President and CEO

Executive Director
142,857 +75.3%
1.75
US$250,000 		142,857 +75.3% 1.75 US$250,000
2021-03-18 2021-03-16 B Purchase
2.5
BASKETT FOREST
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
2.7
Florence Anthony A. Jr.
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
2.1
MAKOWER JOSHUA
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
3.9
Walker Paul Edward
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
3.6
Chang Carmen
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
1.5
Behbahani Ali
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2019-08-15 2019-08-14 B Purchase Hoang Peter L.

President and CEO

Executive Director
10,000 +5.6%
4.62
US$46,200 		10,000 +5.6% 4.62 US$46,200
2018-05-16 2018-05-14 B Purchase Eastern Capital LTD Large shareholder
1,300,000 +32.5%
2.40
US$3,120,000 		1,300,000 +32.5% 2.40 US$3,120,000
2011-04-05 2011-03-23 S Sale CORIN DENIS

President and CFO

Executive Director
160,000 -54.2%
0.12
US$19,200 		160,000 -54.2% 0.12 US$19,200
Explore more

More insider trading research around Marker Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America